Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Research and Clinical Oncology
Published in: Journal of Cancer Research and Clinical Oncology 1/2021

01-01-2021 | ACKNOWLEDGEMENT TO REVIEWERS

Reviewer Acknowledgements 2020

Published in: Journal of Cancer Research and Clinical Oncology | Issue 1/2021

Login to get access

Excerpt

The Editor, Klaus Höfken, and the Vice-Editors-in-Chief, Haiquan Chen, Junho Chung, Helmut E. Gabbert, Andreas Hochhaus, Masanobu Kitagawa, Maurie Markman and Hyori Kim, would like to acknowledge the valuable contributions of the reviewers to the journal. We fully understand the burden and effort that are involved in the reviews, and are very grateful for your support. We rely on your expertise to maintain the standards of excellent science for the Journal of Cancer Research and Clinical Oncology. …
Metadata
Title
Reviewer Acknowledgements 2020
Publication date
01-01-2021
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 1/2021
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-020-03507-0

Other articles of this Issue 1/2021

Journal of Cancer Research and Clinical Oncology 1/2021 Go to the issue

Original Article – Cancer Research

Stratification of Stage III colon cancer may identify a patient group not requiring adjuvant chemotherapy

Original Article – Clinical Oncology

A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis

Review – Cancer Research

MAPK signaling pathway-targeted marine compounds in cancer therapy

Original Article – Cancer Research

BRAFV600E, hypothyroidism, and human relaxin in thyroid carcinogenesis

Review – Clinical Oncology

Risk of lung cancer and renin–angiotensin blockade: a concise review

Original Article – Cancer Research

High Wilms’ tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits